The authors declare that they have no competing interests.
GR performed the case note review with assistance from TW and BB. TW and JM facilitated the case review. GR, BB, NA and TY wrote the paper. All authors read and approved the final manuscript.
The simian parasite Plasmodium knowlesi is recognized as a common cause of severe and fatal human malaria in Sabah, Malaysia, but is morphologically indistinguishable from and still commonly reported as Plasmodium malariae, despite the paucity of this species in Sabah. Since December 2008 Sabah Department of Health has recommended intravenous artesunate and referral to a general hospital for all severe malaria cases of any species. This paper reviews all malaria deaths in Sabah subsequent to the introduction of these measures. Reporting of malaria deaths in Malaysia is mandatory.
Details of reported malaria deaths during 2010-2011 were reviewed to determine the proportion of each Plasmodium species. Demographics, clinical presentations and management of severe malaria caused by each species were compared.
Fourteen malaria deaths were reported, comprising seven Plasmodium falciparum, six P. knowlesi and one Plasmodium vivax (all PCR-confirmed). Of the six P. knowlesi deaths, five were attributable to knowlesi malaria and one was attributable to P. knowlesi-associated enterobacter sepsis. Patients with directly attributable P. knowlesi deaths (N = 5) were older than those with P. falciparum (median age 51 [IQR 50-65] vs 22 [IQR 9-55] years, p = 0.06). Complications in fatal P. knowlesi included respiratory distress (N = 5, 100%), hypotension (N = 4, 80%), and renal failure (N = 4, 80%). All patients with P. knowlesi were reported as P. malariae by microscopy. Only two of five patients with severe knowlesi malaria on presentation received immediate parenteral anti-malarial treatment. The patient with P. vivax-associated severe illness did not receive parenteral treatment. In contrast six of seven patients with severe falciparum malaria received immediate parenteral treatment.
Plasmodium knowlesi was responsible, either directly or through gram-negative bacteraemia, for almost half of malaria deaths in Sabah. Patients with severe non-falciparum malaria were less likely to receive immediate parenteral therapy. This highlights the need in Sabah for microscopically diagnosed P. malariae to be reported as P. knowlesi to improve recognition and management of this potentially fatal species. Clinicians need to be better informed of the potential for severe and fatal malaria from non-falciparum species, and the need to treat all severe malaria with immediate intravenous artesunate.
Lee CE, Adeeba K, Freigang G: Human Plasmodium knowlesi infections in Klang Valley, Peninsular Malaysia: a case series. Med J Malaysia. 2010, 65: 63-65. PubMed
Department of Statistics, Malaysia: Population Distribution and Basic Demographic Characteristics. 2011, Kuala Lumpur: Population and Housing Census of Malaysia 2010, Available: http://www.statistics.gov.my/portal/download_Population/files/census2010/Taburan_Penduduk_dan_Ciri-ciri_Asas_Demografi.pdf. Accessed 18th June 2012
Rundi C: Malaria Elimination in Malaysia. 2011, Sabah, Malaysia: Third annual meeting of the Asia Pacific Malaria Elimination Network (APMEN), Kota Kinabalu, Available: http://apmen.org/apmen-iii-meeting-proceedings/. Accessed 3rd May 2012
World Health Organization: Guidelines for the treatment of malaria. 2010, Geneva: World Health Organization, 2
Scott JAG, Berkley JA, Mwangi I, Ochola L, Uyoga S, Macharia A, Ndila C, Lowe BS, Mwarumba S, Bauni E, Marsh K, Williams TN: Relation between falciparum malaria and bacteraemia in Kenyan children: a population-based, case–control study and a longitudinal study. Lancet. 2011, 378: 1316-1323. 10.1016/S0140-6736(11)60888-X. PubMedCentralCrossRefPubMed
Cunnington AJ, de Souza JB, Walther M, Riley EM: Malaria impairs resistance to Salmonella through heme- and heme oxygenase-dependent dysfunctional granulocyte mobilization. Nat Med. 2012, 18: 120-127. CrossRef
Schwarzer E, Skorokhod OA, Barrera V, Arese P: Hemozoin and the human monocyte-a brief review of their interactions. Parassitologia. 2008, 50: 143- PubMed
Awandare GA, Ouma Y, Ouma C, Were T, Otieno R, Keller CC, Davenport GC, Hittner JB, Vulule J, Ferrell R: Role of monocyte-acquired hemozoin in suppression of macrophage migration inhibitory factor in children with severe malarial anemia. Infect Immun. 2007, 75: 201-210. 10.1128/IAI.01327-06. PubMedCentralCrossRefPubMed
Carney CK, Schrimpe AC, Halfpenny K, Harry RS, Miller CM, Broncel M, Sewell SL, Schaff JE, Deol R, Carter MD: The basis of the immunomodulatory activity of malaria pigment (hemozoin). J Biol Inorganic Chem. 2006, 11: 917-929. 10.1007/s00775-006-0147-0. CrossRef
Yeo TW, Lampah DA, Tjitra E, Gitawati R, Kenangalem E, Piera K, Granger DL, Lopansri BK, Weinberg JB, Price RN, Dufful SB, Celermajer DS, Anstey NM: Relationship of cell-free haemoglobin to impaired nitric oxide bioavailability and perfusion in severe falciparum malaria. J Infect Dis. 2009, 200: 1522-1529. 10.1086/644641. PubMedCentralCrossRefPubMed
Naing DKS, Anderios F, Lin Z: Geographic and ethnic distribution of P knowlesi infection in Sabah, Malaysia. Int J Collab Res Intern Med Public Health. 2011, 3: 391-400.
World Health Organization: Meeting report. 2011, Kota Samarahan, Sawarak, Malaysia: Informal consultation on the public health importance of Plasmodium knowlesi
World Health Organization: Management of severe malaria. Geneva: A practical handbook, In Press, 3
- Deaths due to Plasmodium knowlesi malaria in Sabah, Malaysia: association with reporting as Plasmodium malariae and delayed parenteral artesunate
Giri S Rajahram
Bridget E Barber
Nicholas M Anstey
Tsin W Yeo
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II